TRSVSTXG• 12 Months (Normalized)
TRS vs TXG (TriMas Corporation vs 10x Genomics Inc.)
Showing Closing Date Range from Sep, 16, 2025 to Sep, 16, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
TRS Performance $39.07
-1.01%
TriMas Corporation
Normalized Baseline0.00%
TXG Performance $72.68
+453.54%
10x Genomics Inc.
Normalized Baseline0.00%
Alpha Spread Margin TXG LEADS
-454.55%
TXG outperforming by 454.55%
TRSTXG
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
TRS TXG
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | TRS Price | TRS Gain (%) | TXG Price | TXG Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 16, 2026 | $39.07 | -1.01% | $72.68 | +453.54% | -454.55% |
| Sep 15, 2026 | $38.69 | -1.98% | $74.39 | +466.57% | -468.55% |
| Sep 14, 2026 | $38.24 | -3.12% | $70.11 | +433.97% | -437.09% |
| Sep 11, 2026 | $38.34 | -2.86% | $68.59 | +422.39% | -425.25% |
| Sep 10, 2026 | $38.22 | -3.17% | $66.38 | +405.56% | -408.73% |
| Sep 09, 2026 | $38.24 | -3.12% | $67.29 | +412.49% | -415.61% |
| Sep 08, 2026 | $38.73 | -1.87% | $65.60 | +399.62% | -401.49% |
| Sep 04, 2026 | $39.48 | +0.03% | $62.65 | +377.15% | -377.12% |
| Sep 03, 2026 | $38.85 | -1.57% | $63.22 | +381.49% | -383.06% |
| Sep 02, 2026 | $39.19 | -0.71% | $61.65 | +369.54% | -370.25% |
| Sep 01, 2026 | $38.91 | -1.42% | $59.98 | +356.82% | -358.24% |
| Aug 31, 2026 | $38.78 | -1.75% | $62.45 | +375.63% | -377.38% |
| Aug 28, 2026 | $39.53 | +0.15% | $61.54 | +368.70% | -368.55% |
| Aug 27, 2026 | $39.58 | +0.28% | $64.85 | +393.91% | -393.63% |
| Aug 26, 2026 | $40.14 | +1.70% | $64.26 | +389.41% | -387.71% |
Page 1 of 17